ONC201 (Dordaviprone/TIC10) Variably Modulates Autophagy Response in HPV‐Positive Cervical Cancer Cell Lines in a CLPP‐Independent Manner
Journal of Biochemical and Molecular Toxicology · 2026-11 · 40 (11)
DOI: 10.1002/jbt.71179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 13.11.2026. Verfasst von Sneha O Pathak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Sunandan Divatia School of Science, SVKM's NMIMS (Deemed-to-be) University, V.L. Mehta Road, Vile Parle (West), Mu…. Hauptthemen laut MEDLINE: Autophagy, Uterine Cervical Neoplasms, Endopeptidase Clp, Human Papillomavirus Viruses. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University Grants Commission, SVKM's NMIMS.
Abstract (Originalsprache)
ONC201, also known as dordaviprone or TIC10, a first‐in‐class member of the imipridone family, has recently received fast‐track FDA approval for recurrent diffuse midline glioma. It has shown therapeutic promise and a suitable safety profile in both solid and hematologic malignancies. We recently reported in vitro efficacy of ONC201 in cervical cancer cell lines despite its differential effects on its targets viz. caseinolytic protease (CLPP), TRAIL and DR5 in each of these cell lines. In the current study, we show that ONC201 treatment leads to distinct phenotypic outcomes i.e. significant apoptosis in HeLa cells vs. autophagy in SiHa cells. We further show opposing outcomes upon inhibition of autophagy in both of these cell lines i.e. enhanced apoptosis‐inducing potential of ONC201 against SiHa cells and restrained apoptotic response in the case of HeLa cells. Knockdown studies using siRNA suggest that the autophagy modulation by ONC201 in HeLa cells is independent of its well‐known target CLPP which is widely reported to play a role in cytoprotective autophagy. This is the first report on the ability of ONC201 to modulate the autophagy pathway in cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Sunandan Divatia School of Science, SVKM's NMIMS (Deemed-to-be) University, V.L. Mehta Road, Vile Parle (West), Mumbai, India.
ORCID-Profile: Sneha O Pathak, Ishaan Shah, Tanishka Khedekar, Sonal M Manohar
Förderung
- University Grants Commission
- SVKM's NMIMS
Zitieren
APA
Pathak, S. O., Shah, I., Khedekar, T., & Manohar, S. M. (2026). ONC201 (Dordaviprone/TIC10) Variably Modulates Autophagy Response in HPV‐Positive Cervical Cancer Cell Lines in a CLPP‐Independent Manner. Journal of Biochemical and Molecular Toxicology, 40(11). https://doi.org/10.1002/jbt.71179
Vancouver
Pathak SO, Shah I, Khedekar T, Manohar SM. ONC201 (Dordaviprone/TIC10) Variably Modulates Autophagy Response in HPV‐Positive Cervical Cancer Cell Lines in a CLPP‐Independent Manner. Journal of Biochemical and Molecular Toxicology. 2026;40(11). doi:10.1002/jbt.71179
BibTeX
@article{Pathak2026,
author = {Pathak, Sneha O and Shah, Ishaan and Khedekar, Tanishka and Manohar, Sonal M},
title = {ONC201 (Dordaviprone/TIC10) Variably Modulates Autophagy Response in HPV‐Positive Cervical Cancer Cell Lines in a CLPP‐Independent Manner},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
volume = {40},
number = {11},
doi = {10.1002/jbt.71179}
}
EUVIMED